Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Baylor College of Medicine |
---|---|
Information provided by: | Baylor College of Medicine |
ClinicalTrials.gov Identifier: | NCT00206232 |
The purpose of the study is to collect information about the potential benefit and safety of low dose spironolactone for a patient with diastolic heart failure (DHF) and to determine whether spironolactone can cause the patient's condition to improve.
Condition | Intervention | Phase |
---|---|---|
Heart Failure |
Drug: Spironolactone |
Phase IV |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Novel Treatment for Diastolic Heart Failure in Women |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Inclusion Criteria:
Exclusion Criteria:
Contact: Karla M Kurrelmeyer, MD | 713-798-1405 | karlak@bcm.tmc.edu |
Contact: Yelena Melendez, BBM | 713-790-6220 | melendez@bcm.tmc.edu |
United States, Texas | |
Baylor College of Medicine Heart Clinic | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Yelena Melendez, BBM 713-790-6220 melendez@bcm.tmc.edu | |
Principal Investigator: Karla M Kurrelmeyer, MD |
Principal Investigator: | Karla M Kurrelmeyer, MD | Baylor College of Medicine |
Study ID Numbers: | H - 13988 |
Study First Received: | September 12, 2005 |
Last Updated: | October 30, 2007 |
ClinicalTrials.gov Identifier: | NCT00206232 |
Health Authority: | United States: Institutional Review Board |
Diastolic Heart Failure |
Heart Failure, Diastolic Heart Failure Heart Diseases Spironolactone |
Aldosterone Antagonists Natriuretic Agents Therapeutic Uses Hormone Antagonists Physiological Effects of Drugs |
Diuretics Hormones, Hormone Substitutes, and Hormone Antagonists Cardiovascular Diseases Cardiovascular Agents Pharmacologic Actions |